(Q43093122)

13 November 2017

title

Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats (English)

1 reference

13 November 2017

1 reference

Shenuarin Bhuiyan

1

1 reference

13 November 2017

Kohji Fukunaga

series ordinal

2

1 reference

13 November 2017

publication date

1 March 2010

1 reference

Experimental Biology and Medicine

13 November 2017

published in

1 reference

13 November 2017

volume

235

1 reference

13 November 2017

issue

3

1 reference

13 November 2017

page(s)

356-364

1 reference

The impact of gender on the progression of chronic renal disease

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

The role of gender in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Effects of sex hormones on mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Gender and the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Surgical menopause increases salt sensitivity of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Might DHEA be considered a beneficial replacement therapy in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

DHEA deficiency syndrome: a new term for old age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Role of glomerular endothelial damage in progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Low serum dehydroepiandrosterone sulfate concentration is a predictor for deterioration of urinary albumin excretion in male patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Physicochemical characterization of [3H] DHEA binding in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone inhibits the proliferation of human umbilical vein endothelial cells by enhancing the expression of p53 and p21, restricting the phosphorylation of retinoblastoma protein, and is androgen- and estrogen-receptor independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Silencing of sigma-1 receptor induces cell death in human lens cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Hypoxia and dehydroepiandrosterone in old age: a mouse survival study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Androgen therapy with dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone-induced lipid peroxidation in rat liver mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2009.009177

21 January 2018

Identifiers

DOI

10.1258/EBM.2009.009177

1 reference

13 November 2017

1 reference